Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01934530 · ClinicalTrials.gov registry record · NA
A Randomized Control Trial Testing Connective Tissue Grafts vs. Allograft on Dental Implants
A NA study of Dental Implant Soft Tissue Defects in the Anterior Maxilla, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT01934530: Completed NA study of Dental Implant Soft Tissue Defects in the Anterior Maxilla, sponsored by University of Michigan.
NCT01934530 is a NA study of Dental Implant Soft Tissue Defects in the Anterior Maxilla that has completed, run by University of Michigan. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01934530, a NA study of Dental Implant Soft Tissue Defects in the Anterior Maxilla, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized controlled clinical pilot trial compared the efficacy of two soft tissue grafting methods for correcting esthetic discrepancies associated with non-molar implants in the maxilla. Specifically, it was explored whether defects treated with connective tissue grafts (SCTG) differed in their outcomes from defects treated with acellular dermal matrix allografts (ADM).
Primary Outcome
Change in recession was recorded at baseline, 6 weeks, 3 months and 6 months after grafting.
Conditions Studied
Interventions
- PROCEDURE Soft Tissue Grafting
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2009-08 |
| Est. Completion | 2012-07 |
| Phase | NA |
What the finished NCT01934530 record still lists
NCT01934530 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Dental Implant Soft Tissue Defects in the Anterior Maxilla appearing as the primary indexed condition, and to 1 intervention - of which Soft Tissue Grafting is the first listed.
NCT01934530 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT01934530 about?
NCT01934530 is a clinical study titled "A Randomized Control Trial Testing Connective Tissue Grafts vs. Allograft on Dental Implants". This randomized controlled clinical pilot trial compared the efficacy of two soft tissue grafting methods for correcting esthetic discrepancies associated with non-molar implants in the maxilla. Specifically, it was explored whether defects treated with connective tissue grafts (SCTG) differed in th...
What is the current status of trial NCT01934530?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2009-08. Estimated completion is 2012-07.
What conditions does trial NCT01934530 study?
This clinical trial studies the following conditions: Dental Implant Soft Tissue Defects in the Anterior Maxilla.
What interventions are being tested in trial NCT01934530?
The interventions under investigation include: Soft Tissue Grafting (PROCEDURE).
Who is sponsoring clinical trial NCT01934530?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01934530 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01934530's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia